SAN FRANCISCO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene" or the "Company") (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, today announced the closing ... read more »

SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene" or the "Company") (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, today announced that ... read more »

- Collaboration with Richard Childs, M.D., yields potential first-ever antibodies targeting human endogenous retrovirus associated with renal cell carcinoma SAN FRANCISCO, Calif. and SUZHOU, China, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Adagene, Inc., a platform-driven, clinical-stage biopharmaceutical ... read more »

Hua Gong, M.D., Ph.D. , appointed Chief Operating Officer and Head of Precision Medicine JC Xu, M.D., Ph.D., appointed Chief Scientific Officer Qinghai Zhao, Ph.D.,  appointed Chief Manufacturing Officer Company establishes presence in San Diego as  a  C enter of  E xcellence  for  P recision  M ... read more »

Tanabe Research Labs and Adagene to develop a first-in-class therapeutic with a next-generation masked antibody drug conjugate (ADC), incorporating Adagene's SAFEbody™ technology platform SAN FRANCISCO, and SUZHOU, China, and SAN DIEGO, June 10, 2020 /PRNewswire/ -- Adagene Incorporated, a ... read more »